Human milk oligosaccharides (HMO) pass through the digestive system intact, reaching the colon and exerting prebiotic effects. This prebiotic action in the colon, the most well-known attribute of HMO, helps to promote the colonisation of the gut with ‘good bacteria’ such as the Bifidobacterium and Lactobacillus species.
In addition to this function, it has been shown that HMO can block the adhesion of pathogenic microbes to the epithelial surfaces by acting as soluble ligand analogs thus lowering the risk of viral, bacterial and protozoan parasite infections.
At the mucosal lining HMO exerts some localised effects such as innate immune system modulation and differential cell responses.
It is thought that small amounts of HMO can be absorbed via the small intestine and are subsequently excreted via urination. This means that there are also possible systemic effects of HMO in the immune system or in neuronal development.